GlassScriptPhysician profile
Rex Burkland
NPI 1093401770
$1,959.07
in general payments reported to CMS, 2019-2025
18 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $253 · 2024: $1,273 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $419.36 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $344.72 | 2023-2025 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $232.10 | 2024-2025 | Breztri, Airsupra |
| Phadia US INC. | $141.76 | 2024-2025 | Immunocap |
| Abbott Laboratories | $125.00 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $122.18 | 2024 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.14 | 2024 | |
| Lilly USA, LLC | $97.91 | 2023 | Mounjaro |
| Corcept Therapeutics | $90.75 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $86.64 | 2024 | Xarelto |
| Tg Therapeutics, INC. | $48.91 | 2024 | |
| Pfizer INC. | $30.14 | 2023 | |
| Mallinckrodt Hospital Products INC. | $26.30 | 2024 | Acthar |
| Axsome Therapeutics, INC. | $20.62 | 2025 | Auvelity |
| Genentech USA, INC. | $18.34 | 2024 | Enspryng |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $16.50 | 2024 | Qutenza |
| Ucb, INC. | $16.45 | 2024 | Rystiggo |
| Argenx US, INC. | $14.25 | 2024 | Vyvgart Hytrulo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Burkland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.